AYA STEPS for Symptom Management in Young Adult Cancer Survivors
This study is testing a digital health program called AYA STEPS, which aims to help young adult cancer survivors manage their symptoms and stay engaged with their follow-up medical care. You might be able to join if you are between 18 and 39 years old and have been diagnosed with certain types of cancer, including breast, colorectal, sarcoma, or lymphoma, and have finished your main cancer treatment. The study will compare AYA STEPS to general educational information. Success will be measured by improvements in pain, fatigue, and emotional distress over 12 months. The current recruitment status is unclear.
- Study design
- This is an interventional study planning to enroll 260 participants. It will compare the AYA STEPS program to AYA Educational Information.
- What's involved
- You would participate in six sessions with a clinical psychologist, delivered via video conferencing. Your symptoms will be measured at baseline, 3, 6, and 12 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Your symptoms will be monitored for 12 months after starting the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Pain severity and interference as measured by Brief Pain InventoryBaseline, 3 Months, 6 Months, 12 Months
The Brief Pain Inventory will be used to assess pain severity and interference from pain across important life domains (e.g., general activity, work, relations with others). This measures includes a body map on which the patient can mark the location(s) in which they are experiencing pain, as well as 8 questions on a scale of 0 to 10 with higher scores indicating worse pain severity or pain interference.
- Fatigue as measured by PROMIS Fatigue ScaleBaseline, 3 Months, 6 Months, 12 Months
Fatigue will be assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Fatigue Scale, a 6-item self-report measure of fatigue. Participants are asked to think about the last week when responding to each item (e.g., "In the past 7 days, how run-down did you feel, on average?"), providing ratings on a scale from "not at all" (1) to "very much" (5).
- Emotional distress as measured by PROMIS Depression Short FormBaseline, 3 Months, 6 Months, 12 Months
Depressive symptoms will be assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Depression Short Form, an 8-item measure assessing symptoms of depression in the last week. Responses are on a 5-point scale from "never" (1) to "always" (5).
- Emotional distress as measured by PROMIS Anxiety Short FormBaseline, 3 Months, 6 Months, 12 Months
Symptoms of Anxiety will be assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety Short Form, an 8-item measure assessing symptoms of anxiety in the last week. Responses are on a 5-point scale from "never" (1) to "always" (5).
- Symptom interference as measured by MD Anderson Symptom Inventory (MDASI) Symptom InterferenceBaseline, 3 Months, 6 Months, 12 Months
The MDASI will be used to assess interference of symptoms in daily living (e.g., working, relations with other people, enjoyment of life) over the past month. The MDASI asks patients to rate the severity of 13 symptoms found frequently in patients with various cancers and treatment types on a scale from 0 (symptom "not present") to 10 (symptom "as bad as you can imagine"). This measure also includes 6 questions asking patients to rate the level of symptom interference in six domains (e.g., general activity, mood) on a scale from 0 (did not interfere) to 10 (interfered completely).
- Health care engagement as measured by Patient Participation QuestionnaireBaseline, 3 Months, 6 Months, 12 Months
The Patient Participation Questionnaire will be used to assess participants' health care participation and associated domains (i.e., receipt of information, communication, perceptions of their relationship with the medical team). Participants are asked to indicate their agreement with 17 items related to health care engagement on a 4 point scale: "to a great extent," "to some extent," "to a lesser extent," or "not at all." An additional item asks patients about their overall assessment of their involvement in their healthcare.
- Patient self-assessment of communication competency with health care providers as measured by Medical Communication Competence Scale (MCCS) patient subscaleBaseline, 3 Months, 6 Months, 12 Months
The MCCS patient subscale will be used to assess survivors' perceptions of their competency for communicating and participating in health care. The patient subscale includes 39 items on a scale of 1 to 7, with higher scores reflecting self-perception of better medical communication competence.